Objectives

After participating in this educational activity, attendees should be able to.

1|To discuss the objectives for increased cardiovascular risk and mortality in T1DM.
2|To review the risk factors for increased cardiovascular risk in T1DM.
3|To review dyslipidemia in T1DM and evidence to support early treatment.

 

Faculty

Chelsea Gordner, DO, M.P.H

Assistant Professor, Department of Medicine and Pediatrics

Division of Adult and Pediatric Endocrinology

UMMS-Baystate

Director, Baystate Inpatient Diabetes Service

 

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.                                                               

Session date: 
Tuesday, June 22, 2021 - 12:00pm to 1:00pm
Location: 
MA
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.